Neoadjuvant anti-OX40 (MEDI6469) prior to surgery in head and neck squamous cell carcinoma.R. Bryan Bell, Andrew D. Weinberg, Rom S. Leidner et al.|Journal of Clinical Oncology|2018Cited by 27